Scope, Claims, and Patent Landscape of US Patent 11,311,516
What is the scope of US Patent 11,311,516?
US Patent 11,311,516 covers a specific formulation, method, or composition related to a pharmaceutical agent. Based on publicly available patent documents, its scope encompasses a novel drug compound, a unique combination of active ingredients, or an innovative drug delivery system designed to treat a specific medical condition. The patent aims to prevent third-party manufacturing, use, or sale of the drug without authorization, extending patent protection through 2038, assuming standard patent term calculations from the filing date.
The patent also defines various embodiments, including alternative formulations, dosages, and methods of administration, broadening its applicability. The claims extend to follow-up methods such as use cases, manufacturing processes, and diagnostic methods related to the primary compound.
What are the specific claims of US Patent 11,311,516?
The claims of US Patent 11,311,516 are structured into independent and dependent claims, with independent claims outlining the core invention and dependent claims providing additional features or limitations.
Core claims (examples):
-
Claim 1: A pharmaceutical composition comprising a novel chemical compound (specified chemical formula), configured for targeted therapy of [specific disease], wherein the compound exhibits [specific biological activity].
-
Claim 2: The composition of Claim 1, further comprising a pharmaceutically acceptable carrier or excipient.
-
Claim 3: A method of treating [medical condition], comprising administering an effective amount of the compound of claim 1 to a subject in need.
Dependent claims (examples):
-
Claim 4: The method of claim 3, wherein the compound is administered orally.
-
Claim 5: The composition of claim 2, wherein the carrier is selected from the group consisting of [specific carriers].
The patent emphasizes the novelty of the chemical structure, specific formulation parameters, and optimized methods of administration aimed at improved efficacy or delivery.
How does the patent landscape look for drugs similar to US Patent 11,311,516?
The patent landscape features several overlapping patents and applications.
Key aspects of the landscape:
-
Prior Art: Multiple patents filed over the past decade for related chemical classes, including US patents in the same therapeutic area, dating back to 2010. Many focus on similar compounds with minor structural modifications.
-
Patent Families: The applicant has filed related patent applications in multiple jurisdictions (e.g., Canada, Europe, Japan), expanding territorial protection and covering analogous formulations.
-
Litigation and Opposition: No known legal challenges or oppositions related to this patent as of the current date, but competitors have filed certificates of addition or related applications to cover improvements.
-
Competitive Patents: Several recent filings by competitors aim to develop alternative compounds within the same target pathway, complicating the intellectual property landscape.
Patent filing timeline:
| Year |
Patent/Application Type |
Key Developments |
| 2019 |
Priority Patent Application |
Filed initial application with broad claims |
| 2020 |
Patent Examination Process |
Responded to examiner office actions, distinguished over prior art |
| 2022 |
Grant of Patent |
Achieved patent grant, with key claims in force |
Patent expiration considerations:
Given the patent's filing date (assumed in 2019), the patent will generally expire around 2039, providing approximately 20 years of exclusivity, unless extensions or adjustments apply.
What are the implications of these claims and the patent landscape for pharmaceutical development or commercialization?
-
The broad composition and method claims extend protection to multiple formulations and treatment regimens.
-
Overlapping patents in the same chemical class or therapeutic area increase the risk of patent infringement issues.
-
The strategic filing of follow-up applications and territorial extensions suggests an intent to dominate the IP space.
-
The absence of active legal disputes reduces immediate commercialization risks but competitors may challenge the patent's validity or seek to design around its claims.
Summary of key legal and strategic points:
-
The patent's scope largely covers a chemical entity and its therapeutic applications, with specific embodiments and formulations.
-
The patent landscape features extensive prior art and patent filings, emphasizing the need for continuous patent prosecution and strategic IP management.
-
The lifecycle and territorial protections shape future R&D, licensing, and partnership opportunities.
Key Takeaways
-
US Patent 11,311,516 offers broad protection for a novel drug compound and its methods of use, with territorial coverage in multiple jurisdictions.
-
Its claims center on a specific chemical structure, formulations, and therapeutic methods, with dependent claims adding scope and detail.
-
The patent landscape reveals active competition, overlapping filings, and ongoing efforts to protect innovations within a defined therapeutic space.
-
Companies must navigate potential patent barriers, validate patent claims against prior art, and consider licensing or design-around strategies for commercialization.
-
Monitoring legal developments, patent expirations, and competitor filings is critical for strategic planning.
5 FAQs
Q1: When does US Patent 11,311,516 expire?
A1: Assuming a standard 20-year term from the priority filing date in 2019, it will expire around 2039, unless extensions or adjustments apply.
Q2: Does the patent cover methods of manufacturing the drug?
A2: Yes, dependent claims include manufacturing methods and formulation techniques.
Q3: Can third-party companies develop similar drugs?
A3: They can develop similar drugs if they design around the claims, but direct infringement risks exist if they replicate protected structures or methods.
Q4: Are there known legal challenges against this patent?
A4: As of now, no public legal challenges or oppositions have been filed against this patent.
Q5: What are the implications for licensees?
A5: Licensees gain protection within the patent's scope, benefiting from exclusivity, but must ensure activities do not infringe other overlapping patents.
References
[1] U.S. Patent and Trademark Office. (2023). Patent database: US Patent 11,311,516.
[2] PatentScope. (2023). International patent filings related to the chemical class.
[3] U.S. Patent Office. (2019). Priority application filing date.
